Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your research with custom RNA oligos consistently manufactured to your exact specifications. From routine siRNA to complex therapeutic oligonucleotides, we deliver high-quality synthetic RNA with advanced modification options for enhanced stability and efficacy.
Trusted by leading research and pharmaceutical institutions
siRNA, miRNA, sgRNA up to 160 nt
ISO 13485 GMP-grade available
2'-OMe, 2'-F, LNA, PS backbone
Our platform combines established phosphoramidite chemistry with advanced modification capabilities to deliver high-quality RNA oligos for research and therapeutic applications.
Proven solid-phase synthesis using phosphoramidite chemistry with optimized coupling efficiency. Our proprietary synthesis platform delivers more full-length RNA product with rigorous QC at every step.
Every RNA oligo undergoes rigorous quality control including MALDI-TOF mass spectrometry and HPLC analysis. GMP-grade manufacturing available for therapeutic applications.
Extensive modification options including 2'-OMe, 2'-F, LNA, phosphorothioate, and fluorescent dyes.
Every order includes detailed mass spectrometry and purity analysis reports.
Free consultation for sequence design and modification selection.
Get a customized quote for your custom RNA synthesis needs.
Industry-leading synthesis platforms ensuring high-quality output for every project.
Optimized phosphoramidite chemistry for RNA synthesis, delivering high-quality full-length products with superior purity.
Every RNA oligo undergoes MALDI-TOF mass spectrometry and HPLC analysis to ensure sequence accuracy and purity.
200+ modification options including sugar modifications, backbone changes, and fluorescent labels for diverse applications.
Comprehensive specifications to meet your research requirements.
| Parameter | Standard RNA | Long RNA | siRNA |
|---|---|---|---|
| Length Range | 5 - 80 nt | 81 - 160 nt | 19 - 25 bp duplex |
| Scale Range | 0.025 - 10 μmol | 0.25 - 5 μmol | 50 - 200 nmol |
| Purification | Desalt, Cartridge, HPLC | HPLC, PAGE | HPLC purified |
| Quality Control | MALDI-TOF MS | MALDI-TOF MS | MALDI-TOF, PAGE |
| Modifications | 200+ options | Custom | Standard + custom |
Our proven 5-step workflow ensures quality and efficiency at every stage.
Submit sequence and modification requirements
Sequence verification and optimization
Phosphoramidite-based synthesis
MALDI-TOF MS and HPLC analysis
Lyophilized with comprehensive report
Our RNA synthesis services support research and development in multiple fields.
High-quality siRNA and miRNA for effective gene knockdown experiments. Our modified oligos ensure enhanced stability and sustained silencing effects in diverse cell types.
ASOs, aptamers, and anti-sense oligonucleotides with chemical modifications for enhanced therapeutic potential. GMP-grade manufacturing available for clinical applications.
Fluorescently labeled probes and primers for qPCR, NGS, and molecular detection assays. High purity ensures reliable results in diagnostic applications.
Trusted by researchers worldwide for quality and reliability.
"The RNA oligo quality is consistently excellent. MALDI-TOF verification gives us confidence in every experiment. Highly recommend for any RNAi project."
"Fast turnaround and excellent technical support. The modification options available have been crucial for our therapeutic oligonucleotide development."
"We've been using this service for our CRISPR and diagnostic projects. Consistent quality and reliable results every time. The GMP option is excellent."
Our platform is backed by peer-reviewed research.
McKenzie LK, El-Khoury R, Thorpe JD, et al. Chemical Society Reviews. 2021.
Comprehensive review of modified nucleic acids for therapeutic oligonucleotides including ASOs and siRNAs.
Lu X, Li J, Li C, Lou Q, Peng K, Cai B, Liu Y, Yao Y, et al. ACS Catalysis. 2022.
Engineering TdT for enzymatic DNA/RNA synthesis with reversible terminators enabling high-throughput production.
Featherston AL, Kwon Y, Pompeo MM, Engl OD, et al. Science. 2021.
Breakthrough in catalytic asymmetric synthesis of all possible oligonucleotide stereoisomers.
Ma Y, Zhang Z, Jia B, Yuan Y. Heliyon (Cell Press). 2024.
Comprehensive review of automated synthesis platforms and biofoundries for accurate high-throughput nucleic acid production.
Dousis A, Ravichandran K, Hobert EM, Moore MJ, Rabideau AE. Nature Biotechnology. 2022.
Engineered T7 RNAP variant for producing high-quality mRNA with reduced dsRNA impurities.
Find answers to common questions about our service.
Get a customized quote for your Custom RNA Synthesis project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.